Status:

UNKNOWN

Effect of Smoking on Activated Clotting Time Values During Coronarography and Angioplasty

Lead Sponsor:

Central Hospital, Nancy, France

Conditions:

Ischemic Cardiomyopathy

Eligibility:

All Genders

18-90 years

Brief Summary

analyzing influence of smoking on patients anti-coagulation status as assessed by ACT measurements during coronary angioplasty

Detailed Description

During angioplasty, activated clotting time (ACT) measurements are recommended to attest the correct anticoagulation level and if anticoagulation levels are suboptimal after the two first boluses, add...

Eligibility Criteria

Inclusion

  • any patient older than 18 years needing a diagnostic coronarography was eligible for enrollment

Exclusion

  • unconscious patient
  • any patient presenting with one of the following characteristic known to impact either on ACT or aPTT measurements as: oral anticoagulation medication (anti-vitamin K and non-vitamin K antagonist oral anticoagulants \[NOAC\]), fondaparinux or LMWH usage, coagulopathy defined as prothrombin time \< 50 % or thrombopenia \< 50 000 G/L, declared or observed thrombophilia defined as antithrombin \< 50%, baseline aPTT values with a ratio patient/control \> 1.2 presence of lupus anticoagulant, connective tissue disease, active cancer
  • a person as defined by the law articles L. 1121-5, L. 1121-7 et L1121-8 of the Code de la santé publique, France (pregnant, parturient women or breastfeeding women, legally adult patient under legal protection measure \[tutelage, protection of vulnerable adults\]),
  • a person as defined by the law articles L. 3212-1 et L. 3213-1 of the Code de la santé publique, France (legally adult patient unable to consent, person with legal or administrative freedom restriction or person under psychiatric treatment)

Key Trial Info

Start Date :

January 6 2020

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

September 30 2022

Estimated Enrollment :

120 Patients enrolled

Trial Details

Trial ID

NCT04897997

Start Date

January 6 2020

End Date

September 30 2022

Last Update

May 24 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University Hospital Nancy Brabois

Vandœuvre-lès-Nancy, France, 54500